Correction: Reducing the harms of xylazine: clinical approaches, research deficits, and public health context

Detalles Bibliográficos
Autores principales: Zagorski, Claire M., Hosey, Rebecca A., Moraff, Christopher, Ferguson, Aaron, Figgatt, Mary, Aronowitz, Shoshana, Stahl, Natalie E., Hill, Lucas G., McElligott, Zoe, Dasgupta, Nabarun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10683201/
https://www.ncbi.nlm.nih.gov/pubmed/38012764
http://dx.doi.org/10.1186/s12954-023-00903-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10683201/
https://www.ncbi.nlm.nih.gov/pubmed/38012764
http://dx.doi.org/10.1186/s12954-023-00903-w

Ejemplares similares